Skip to content

Fat loss on HIV therapy averages 13% a year, reports Australian group

HIV and SARS: HIV co-discoverer speculates on impact

Medicines Control Council blocks generic anti-HIV drugs imports from Swaziland into South Africa

International Day of Action supports fight for HIV drugs in South Africa

American HIV-positive women have high prevalence of other chronic viral infections

Update: Cotrimoxazole Prophylaxis

Update: Combining ARVs with treatment for tuberculosis

Update: Nevirapine-based fixed-dose combination ARVs

AIDS deaths down, but new causes of death at largest UK HIV clinic

Gout and HIV: another symptom of lipodystrophy

Being older and having an STI increases chances of being HIV seminal super-shedder

GSK cuts price of HIV drugs to poorest countries

Fisting, drug use, syphilis; risk factors for hepatitis C transmission in HIV-positive gay men

HIV-positive women in the UK report high levels of sexual abstinence and psychological distress

Efavirenz more durable than nevirapine, but CNS toxicity underestimated

Avoid Zerit, Trizivir in first-line treatment, new UK guidelines recommend

Switch to Trizivir after 6 months induction just as effective as multi-class therapy

Chinese experts ask why AIDS patients resistant to SARS